The present invention relates to the use of a protein, GASP1, comprising at least one follistatin domain to modulate the level or activity of growth and differentiation factor-8 (GDF-8). More particularly, the invention relates to the use of GASP1 for treating disorders that are related to modulation of the level or activity of GDF-8. The invention is useful for treating muscular diseases and disorders, particularly those in which an increase in muscle tissue would be therapeutically beneficial. The invention is also useful for treating diseases and disorders related to metabolism, adipose tissue, and bone degeneration.

 
Web www.patentalert.com

< Modulators of chemokine receptor activity, crystalline forms and process

> Apparatus and method for easing use of a spectrophotometric based noninvasive analyzer

> Modulation of survivin expression

~ 00523